• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Elimination of infused arginine-vasopressin and its long-acting deaminated analogue in rats.

作者信息

Gazis D, Sawyer W H

出版信息

J Endocrinol. 1978 Aug;78(2):179-86. doi: 10.1677/joe.0.0780179.

DOI:10.1677/joe.0.0780179
PMID:702013
Abstract

Arginine-vasopressin (AVP) and deamino-arginine-vasopressin (dAVP) were infused into rats. When the concentrations of the two peptides were steady, the rate of clearance of AVP from the plasma was six times the rate of clearance of alphaAVF. Only 6% of the infused AVP was excreted unchanged in the urine, whereas approximately 100% of the dAVP was excreted. When the infusions were stopped, AVP disappeared from the plasma much more rapidly than dAVP. The plasma concentrations of the two peptides did not decay as simple exponential functions, suggesting that both AVP and dAVP entered a slowly exchanging compartment or compartments during prolonged infusion. These differences in the metabolic clearance of AVP and dAVP may well explain the prolonged antidiuretic effect of dAVP in rats.

摘要

相似文献

1
Elimination of infused arginine-vasopressin and its long-acting deaminated analogue in rats.
J Endocrinol. 1978 Aug;78(2):179-86. doi: 10.1677/joe.0.0780179.
2
DDAVP (1-desamino-8-D-arginine vasopressin) clearance rate.去氨加压素(1-去氨基-8-D-精氨酸加压素)清除率。
Acta Endocrinol (Copenh). 1984 Oct;107(2):204-6. doi: 10.1530/acta.0.1070204.
3
Synthesis and some pharmacological properties of deamino(4-threonine,8-D-arginine)vasopressin and deamino(8-D-arginine)vasopressin, highly potent and specific antidiuretic peptides, and (8-D-arginine)vasopressin and deamino-arginine-vasopressin.去氨基(4-苏氨酸,8-D-精氨酸)加压素、去氨基(8-D-精氨酸)加压素、高效特异性抗利尿肽、(8-D-精氨酸)加压素及去氨基精氨酸加压素的合成与某些药理特性
J Med Chem. 1976 Jun;19(6):842-5. doi: 10.1021/jm00228a023.
4
Synthesis and some pharmacological properties of 18 potent O-alkyltyrosine-substituted antagonists of the vasopressor responses to arginine-vasopressin.18种强效的O-烷基酪氨酸取代的精氨酸加压素血管升压反应拮抗剂的合成及某些药理特性
J Med Chem. 1985 Oct;28(10):1485-91. doi: 10.1021/jm00148a019.
5
Urinary and metabolic clearances of arginine vasopressin in normal subjects.正常受试者中精氨酸加压素的尿清除率和代谢清除率
Am J Physiol. 1986 Aug;251(2 Pt 2):R365-70. doi: 10.1152/ajpregu.1986.251.2.R365.
6
Design of potent and selective agonists for the human vasopressin V1b receptor based on modifications of [deamino-cys1]arginine vasopressin at position 4.基于对[脱氨基-半胱氨酸1]精氨酸加压素4位的修饰设计人血管加压素V1b受体的强效和选择性激动剂。
J Med Chem. 2004 Apr 22;47(9):2375-88. doi: 10.1021/jm030611c.
7
Further in vivo evidence for antagonist-to-antidiuretic action of arginine vasopressin.精氨酸加压素抗利尿作用拮抗剂的进一步体内证据。
Am J Physiol. 1983 Nov;245(5 Pt 1):R713-9. doi: 10.1152/ajpregu.1983.245.5.R713.
8
2-O-alkyltyrosine derivatives of 1-deamino-arginine-vasopressin: highly specific and potent antidiuretic agonists.1-脱氨基-精氨酸加压素的2-O-烷基酪氨酸衍生物:高特异性强效抗利尿激动剂
J Med Chem. 1989 Jan;32(1):244-7. doi: 10.1021/jm00121a043.
9
Effects of proteolytic enzyme inhibitors on the nasal absorption of vasopressin and an analogue.
Pharm Res. 1991 Sep;8(9):1175-9. doi: 10.1023/a:1015862603939.
10
Impermeability of the blood-cerebrospinal fluid barrier to 1-deamino-8-D-arginine-vasopressin (DDAVP) in patients with acquired, communicating hydrocephalus.
Eur J Clin Invest. 1984 Dec;14(6):435-9. doi: 10.1111/j.1365-2362.1984.tb01209.x.

引用本文的文献

1
Insulin-regulated aminopeptidase is required for water excretion in response to acute hypotonic stress.胰岛素调节氨肽酶对于应对急性低渗应激时的水排泄是必需的。
Am J Physiol Renal Physiol. 2023 Jun 1;324(6):F521-F531. doi: 10.1152/ajprenal.00318.2022. Epub 2023 Mar 30.